Compare AbCellera Biologics Inc (ABCL) vs Airbnb, Inc. (ABNB) Price & Performance

AbCellera Biologics IncTrade

Airbnb, Inc.Trade

Price performance (Past 24H)

Key statistics

AbCellera Biologics Inc vs Airbnb, Inc. — how do they compare? AbCellera Biologics Inc trades at $8.93 (market cap $2.85B), while Airbnb, Inc. trades at $184.79 (market cap $110.60B). The key difference: Airbnb, Inc. is far larger — about 38.8× AbCellera Biologics Inc's market cap, and Airbnb, Inc. is trading nearer its 52-week high, AbCellera Biologics Inc nearer its low. Which is the better fit depends on your goals.

	ABCL	ABNB
Market Cap	$2.85B	$110.60B
Sector	Health	Consumer Cyclical
52-Week High	$9.76	$184.98
52-Week Low	$2.78	$111.54
Enterprise Value	$2.45B	$101.02B

View details →View details →

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

AbCellera Biologics Inc

ABCL's stock surged 6.13% to $6.93, driven by positive Phase 2 trial results for its menopause drug ABCL635, which showed an 83% reduction in hot flashes. Despite a bullish technical signal and strong analyst consensus (91.67% buy ratings), the company faces fundamental challenges with a net income margin of -248.84% and negative cash flow from operations. Revenue declined from $485M in 2022 to $75M in 2025, though recent news highlights potential from clinical advancements and a collaboration with Vertex.

The outlook is mixed: near-term optimism hinges on drug development success, but high valuation ratios (P/S of 31.63) and persistent losses pose risks. Investors should weigh the 54% upside to the $10.67 price target against cash burn and competitive pressures in biotech.

Airbnb, Inc.

No Aura AI signal available yet.

Aura AI is an analytical signal, not financial advice — do your own research.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

ABCL

View details →

ABNB

Airbnb stock hits new high on strong Q2 results and AI-driven growth strategyAndrew Wynn · 4 days agoBullish Airbnb stock jumps 15% after strong growth quarter driven by AI innovationsNew York Post · 4 days agoBullish Airbnb cuts feature launch time by 60% using AI, boosting product development and customer support efficiency.TechCrunch · 4 days agoBullish View details →

About AbCellera Biologics Inc

AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.

About Airbnb, Inc.

Airbnb, Inc. operates an online marketplace for travel information and booking services. The Company offers lodging, home stay, and tourism services via websites and mobile applications. Airbnb serves clients worldwide.